Evaluating the effect of oral iron chelators on markers of renal function in beta-thalassemia major
Phase 2
- Conditions
- Thalassaemia Major.Beta thalassemia
- Registration Number
- IRCT20090111001545N4
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
beta thalassemia major patients receiving deferasirox for more than a year
beta thalassemia major patients receiving deferoxamine for more than a year
healthy control group
Exclusion Criteria
previous diagnosis of congenital diseases
previous diagnosis of renal functions diseases
acute sign and symptoms of acute kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Renal function markers. Timepoint: after on year treatment. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method